Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species
An enavogliflozin ophthalmic solution (DWRX2008) is being developed to treat diabetic retinopathy and macular edema. This study evaluated the ocular distribution and plasma pharmacokinetics (PKs) of enavogliflozin in animal species. A sample of [<sup>14</sup>C] enavogliflozin was ocularl...
Saved in:
Main Authors: | Mingui Jang (Author), Minsung Kang (Author), Eunseok Lee (Author), Dongseong Shin (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and Tissue Distribution of Enavogliflozin in Mice and Rats
by: Minyeong Pang, et al.
Published: (2022) -
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
by: Min-Soo Kim, et al.
Published: (2023) -
A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension
by: Tao Wang, et al.
Published: (2022) -
Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis
by: Anxo Fernández-Ferreiro, et al.
Published: (2017) -
Clinical Ocular Exposure Extrapolation for a Complex Ophthalmic Suspension Using Physiologically Based Pharmacokinetic Modeling and Simulation
by: Maxime Le Merdy, et al.
Published: (2024)